Navigation Links
RPA in Medical News

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...velopment programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim((R)) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia((R)) - a ...

Renal Physicians Association Participates in PEAK Campaign

...d Accountability in Kidney Care (PEAK) initiative. rpa is a member of KCP, a coalition which includes gro...mmend KCP for launching the PEAK initiative," said rpa President Dr. Edward Jones. "While the evidence b... in the overall improvement of CKD care quality." rpa has developed evidence-based clinical practice gui...

PharmAthene Reports Year End 2008 Financial Results

...t contracts supporting the development of SparVax(TM), our third generation rpa anthrax vaccine candidate, and RypVax(TM). Research and development ex... - a recombinant dual antigen vaccine for plague A third generation rpa anthrax vaccine. For more information about PharmAthene, ...

The Renal Physicians Guide to Nephrology Practice, 6th Edition

...nsure quality care under the highest standards of medical practice for patients with kidney disease and related disorders. For more information about rpa please visit www.renalmd.org or call 301-468-3515. ...

Cogdell Spencer Breaks Ground on Projects in Tennessee and North Carolina

...cian groups. Erdman is the developer on the project, Robins & Morton of Birmingham, Alabama is the general contractor on this project while rpa Design, based in Charlotte, North Carolina, is the project architect on both the Tennessee and Mebane projects. Upon completion, Cogdell Spencer Inc....

Renal Physicians Association 2009 Annual Meeting

...and relevant to today's nephrology practitioners. rpa will convene national leaders and experts in their... Beyond the rich and pertinent content that the rpa meeting offers, this unique venue allows nephrolog...rapple with every day. Register today for the 2009 rpa Annual Meeting March 20-23 in Baltimore, Maryland ...

Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine

... UK site has been developing processes and making protein-based biopharmaceuticals to cGMP since 1998. Process development and cGMP manufacture of the rpa anthrax vaccine and the plague vaccine have been carried out at this site since 2000. Avecia Biotechnology Inc. is a leader in the field of contract m...

More>>

RPA in Medical Technology

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

ANNAPOLIS, Md., April 28 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it will be hosting a conference call for investors on Wednesday, April 29th beginning at ...

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

...tality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rpa anthrax vaccine. For more information about PharmAthene, please visit www.PharmAthene.com . Statement on Cautionary Factors ...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

... and procure 25 million doses of a next generation rpa anthrax vaccine for the country's civilian biomedi...ced development and procurement of next generation rpa anthrax vaccines." About SparVax(TM) Spar...gen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully huma...

Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology

...tality associated with exposure to chemical nerve agents RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rpa anthrax vaccine. For more information about PharmAthene, please visit www.PharmAthene.com . Statement on Cautionary Factors ...

PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)

...t development programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rpa anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R) - a nove...

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

... development programs include: -- SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rpa anthrax vaccine -- Valortim(R) -- a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R) -- a no...

ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.

...s rPA102 anthrax vaccine is composed of a purified rpa and an aluminum salt adjuvant routinely used in ma...l be mirrored in testing of Viprovex with VaxGen's rpa antigen." Initial studies in a well-established m...chael Wilhelm. "With the previous success that the rpa vaccine has seen in the lab against anthrax we are...
RPA in Biological News

Kidney function discovery sheds light on genetic complexity of disease

... due to an inherited abnormality of a specific pump on the surface of kidney cells," Professor Rasko explains. The teams from Centenary Institute, rpa and ANU have now unravelled the genetic explanation by showing that not one, but up to four different pumps present in the kidney determine whether or...

DNA ends: Common tool, different job

... Stn1, they dug up Rpa2, the middle subunit of the rpa complex. In particular, Stn1 and Rpa2 share simila...e just like their counterparts in the conventional rpa complex. However, Stn1 and Ten1 have the same pred...tial biological parallels between the conventional rpa complex and the newly discovered t-RPA complex. ...
RPA in Biological Technology

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company's propos...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program

ANNAPOLIS, Md., Sept. 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Inst...

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

...elopment programs include: SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim((R)) -- a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia((R)) -- ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Pr...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... activities related to the SparVax(TM), RypVax(TM) and our third generation rpa anthrax vaccine programs, which we acquired in the second quarter of 2008. ...combinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

...t programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia(R) - a ...

PharmAthene Announces $5.5 Million Public Equity Offering

...t programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia(R) - a ...

PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009

...t programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection Protexia(R) - a ...

PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting

...These results suggest that SparVax(TM) may be a promising second generation rpa anthrax vaccine candidate for civilian defense against anthrax infection. ...combinant protective antigen (rPA) anthrax vaccine Third generation rpa anthrax vaccine Valortim(R) - a fully human monoclonal antibody for...

PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel

...opment programs include: -- SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine -- Third generation rpa anthrax vaccine -- Valortim(R) - a fully human monoclonal antibody for the prevention and treatment of anthrax infection -- Protexia(R...

More>>

RPA in Biological Dictionary

Primase

...subunits, which catalyzes the ... ... DnaB Helicase and Its Complex with a Domain of DnaG Primase [My Copy] ... posted to atr primase rad17 rfc rpa by DNAReplication on 2008-01-02 18:45:20 as ... The European ... DNA primase synthesizes the RNA primers for the Okazaki ... In Escherichia coli,...
Other Tags
(Date:7/13/2014)... According to the Kidney Disease Solution book review recently updated ... what to do to eliminate the root cause of ... review that readers can easily learn what foods to avoid ... Vkool also informs in its Kidney Disease Solution review that ... naturally. The book consists of a collection of natural remedies ...
(Date:7/13/2014)... A Xarelto lawsuit webpage has been launched ... with the most current information regarding serious internal bleeding ... as well as the growing number of Xarelto ... The law firm is now offering free legal evaluations ... bleeding and related complications while using Xarelto, including:, ...
(Date:7/13/2014)... WA (PRWEB) July 13, 2014 ... Woolcott, who commented, “As a parent of a special ... underserved need in the Seattle community for contemporary special ... provide an important alternative to students and families in ... best practices and environment for special education. We welcome ...
(Date:7/13/2014)... Arbor, MI (PRWEB) July 13, 2014 If ... learning program he has just launched at http://www.HealthYourself101.com ... of visceral obesity. , Power has set out to ... its ill effects that’s actually – dare we say it? ... “The program,” says Power, “aims to engage the remote learner ...
(Date:7/13/2014)... 2014 According to the Living With ... a comprehensive guide that features a series of tips ... (keratosis pilaris). This guide consists of 14 chapters ... Pilaris? ,     Chapter 2: What Cause KP? , ... Have KP? ,     Chapter 4: Keratosis Pilaris Treatment ...
Breaking Medicine News(10 mins):Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3
(Date:7/10/2014)... in New Mexico, nearly every public golf course is ... potable water supplies. Across the U.S. Southwest as a ... treated effluent. Reusing the effluent increases the sustainability of ... alike fertilize their lawns during the growing season. The ... State University turfgrass expert has a new vision for ...
(Date:7/10/2014)... NEW YORK , June 27, 2014 /PRNewswire/ ... against Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: ... action, filed in United States District Court, Middle ... Division, is on behalf of a class consisting ... otherwise acquired Provectus securities between December 17, 2013 ...
(Date:7/10/2014)... CORAL SPRINGS, Florida , July 1, 2014 ... smart wallets pave way for convenience and improved security: NXT-ID, ... Google Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... ) and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: ... market, is pleased to announce that the second series of ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
Other Contents